Clinical Trial Update: Pharmacokinetic Study to Determine Time to Steady-state [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study to determine time to steady-state; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Male Hypogonadism

Snippet

Sponsor: Clarus Therapeutics, Inc. | Conditions: Male Hypogonadism, Primary Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2020-12-11